INT4762

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.45
First Reported 1992
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 5
Total Number 5
Disease Relevance 0.68
Pain Relevance 0.80

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (DHCR24) small molecule metabolic process (DHCR24) Golgi apparatus (DHCR24)
endoplasmic reticulum (DHCR24) cytoskeleton (DHCR24) nucleus (DHCR24)
Anatomy Link Frequency
nucleus 1
DHCR24 (Homo sapiens)
Pain Link Frequency Relevance Heat
amygdala 4 99.04 Very High Very High Very High
Arthritis 3 94.64 High High
Enkephalin 1 92.72 High High
substance P 1 84.76 Quite High
Dynorphin 1 83.16 Quite High
antagonist 2 75.16 Quite High
Neuropeptide 1 75.00 Quite High
Pain 3 65.56 Quite High
Inflammation 1 55.64 Quite High
Analgesic 1 54.76 Quite High
Disease Link Frequency Relevance Heat
Arthritis 3 94.64 High High
Acute Renal Failure 1 77.52 Quite High
Anxiety Disorder 4 67.72 Quite High
Pain 2 65.56 Quite High
INFLAMMATION 2 55.64 Quite High
Hemolysis 1 25.00 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
When atropine-induced suppression of the DCE, Fos pattern was modified in the mPFC with a change in Fos immunoreactivity, but no longer associated with the DCE.
Negative_regulation (suppression) of DCE
1) Confidence 0.45 Published 2006 Journal Neuropharmacology Section Abstract Doc Link 16678862 Disease Relevance 0.18 Pain Relevance 0.19
Compared to the normal DCE, atropine-induced disruption of the DCE was associated with an increase of the amount of Fos immunoreactive neurons within the central nucleus of the amygdala.
Negative_regulation (disruption) of DCE in nucleus associated with amygdala
2) Confidence 0.29 Published 2006 Journal Neuropharmacology Section Abstract Doc Link 16678862 Disease Relevance 0.20 Pain Relevance 0.20
Both SPE and DCE were significantly decreased 15 days after the intraarticular injection.
Negative_regulation (decreased) of DCE
3) Confidence 0.14 Published 1992 Journal Neurosci. Lett. Section Abstract Doc Link 1279476 Disease Relevance 0.18 Pain Relevance 0.34
Experiments with P450-selective chemical inhibitors and monoclonal anti-P450 antibodies showed that furafylline, a mechanism-based inhibitor CYP1A2, and anti-CYP1A2 antibody markedly inhibited 6-MNA formation, whereas inhibitors for other P450s did not show significant inhibitory effects.
Negative_regulation (inhibitors) of P450-selective
4) Confidence 0.02 Published 2009 Journal Drug Metab. Dispos. Section Abstract Doc Link 19204080 Disease Relevance 0.06 Pain Relevance 0.08
Patients were divided in 2 groups according to the GFR percent change in comparison to the baseline value found 24 hours after CS (deltaGFR24): Group 1, deltaGFR24 decrease higher than 20% (n = 11) and Group 2, deltaGFR24 decrease < or = 20% or deltaGFR24 increase (n = 10).
Negative_regulation (decrease) of deltaGFR24
5) Confidence 0.01 Published 2000 Journal Ren Fail Section Abstract Doc Link 10901186 Disease Relevance 0.08 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox